FDA approves Lupin's generic drug for hypertension

By Lisa Kerner

Charlotte, N.C., June 23 - The Food and Drug Administration has approved Lupin Ltd.'s abbreviated New Drug Application for Quinapril Tablets USP (5 mg, 10 mg, 20 mg and 40 mg).

Quinapril Tablets USP is the AB-rated generic equivalent of Pfizer's Accupril Tablets for the treatment of hypertension, according to a company news release.

Total sales of Quinapril Tablets were $300 million for the 12 months ended December 2005, the company said, based on IMS data.

Lupin, based in Mumbai, India, manufactures drugs for the treatment of tuberculosis, bacterial infections and cardiovascular disease.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.